circ-FSCN1 affects ferroptosis and cell viability in NSCLC via the miR-506-3p/SLC7A1 pathway Authors: Wenxi Yu, Jiao Liu, Mingming Jin, Gang Huang, Qingqing Huang Published: 2026 ABSTRACT Highlights•The expression of hsa_circ_0004175 (circ-FSCN1) was elevated in NSCLC tissues and cells.•The downregulation of circ-FSCN1 inhibited cellular migration and proliferation in the experiments.•miR-506-3p downregulation or SLC7A1 overexpression reversed the suppression effects of sh-circ-FSCN1 on the proliferation and migration ability of H1299 and A549 cells.•SLC7A1 overexpression reversed the inhibitory effects of miR-506-3p on the proliferation and migration ability of H1299 and A549 cells.•Inhibiting miR-506-3p or overexpressing SLC7A1 reversed the enhancing effects of sh-circ-FSCN1 on ROS accumulation in H1299 and A549 cells.Keywords: circ-FSCN1, Ferroptosis, miR-506-3p, SLC7A1, NSCLC Introduction Lung cancer (LC), which is a malignant tumor, has a poor prognosis with high morbidity. Non-small cell lung cancer (NSCLC) is the most general LC type (occupying ∼85%) [1]. NSCLC is the main reason for cancer-relevant mortality. Although many drugs have been developed and are utilized to suppress tumor progression, the recurrence, metastasis, and chemotherapy resistance are still important causes of the poor prognosis in tumor patients [2]. Various studies have confirmed the significant role of circular RNA (circRNA) in the progression of various human cancers, including NSCLC [[3], [4], [5]]. circular RNAs (circRNAs) are regulatory RNAs with a covalently closed single-stranded ring conformation produced by back-splicing of the precursor mRNA exon [6]. Recent investigations have shown that circRNAs participate in various biological processes, including autoimmune diseases, brain development, and tumorigenesis [[7], [8], [9], [10]]. The role and effects of circRNAs in different cancers have been widely reported, suggesting that circRNAs may be potential biomarkers or therapeutic targets. The present investigation showed that circ-FSCN1 expression was increased in NSCLC tissues and cells. circ-FSCN1 downregulation inhibited proliferation and migration in experiments by regulating miR-506-3p/SLC7A1–mediated ferroptosis in NSCLC. Materials and methods Ethics statement In this investigation, 4-week-old BALB/c nude female mice (SLARC, Shanghai, China) were used. The ethics committee at Shanghai University of Medicine and Health Sciences approved and supervised the animal care and experiments. Strand-specific library and next-generation sequencing Total RNA was obtained from NSCLC tissues using TRIzol reagent (Invitrogen Corporation, Carlsbad, CA, USA). A total of 3 μg RNA without ribosomal or ncRNA was used to prepare the next-generation sequencing (NGS) libraries with VAHTS Library Prep Kit (Vazyme Biotech Co., Ltd, Nanjing, China). Purified RNA was maintained by 40 U RNase R (Epicenter Technologies Pvt., Ltd., Thane, India). The RNA-seq library was made by Shanghai Aksomics Biotechnology Co., Ltd. (Shanghai, China). Tissue chips and FISH For investigating circ-FSCN1 expression, cells and NSCLC tissue samples (n = 35) were obtained from Shanghai University of Medicine and Health Sciences using special probes designed for circ-FSCN1 (Dig-5′-CTGCGACTATAACAAGGTATGGACCTGTCTGC-3′-Dig). For FISH, we counterstained nuclei with DAPI (Yeasen Biotechnology, Shanghai, China) and captured images using a Zeiss LSM 700 confocal microscope (Carl Zeiss GmbH, Oberkochen, Germany). Cell culture BEAS-2B, A549, H1299, H226, and MES-1 cell lines were purchased from the Chinese Academy of Sciences (Shanghai, China). The cells were cultured in DMEM with penicillin-streptomycin (Gibco, USA). RNA overexpression miR-506-3p inhibitor (5ʹ-UCUACUCAGAAGGGUGCCUUA-3ʹ), miR-506-3p mimic (miRNA mimic: 100 nM, mature miRNA for miR-506-3p: 5′-UAAGGCACCCUUCUGAGUAGA-3′), circ-FSCN1 silencing vector (sh-circ-FSCN1, siRNA concentration 20 nM, siRNA for circ-FSCN1: 5′-CTATAACAAGGTATGGACCTGTC-3′), and SLC7A1 overexpression vector obtained from RiboBio (Guangzhou, China) were used for transfections. Quantitative reverse transcription PCR analysis Total RNA was isolated from tumor cells or tissues using a commercial kit and following protocols (Vazyme Biotech Co., Ltd, Nanjing, China). RNA concentration and purity were determined by detecting absorbance using the NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, USA). The conditions applied for RT-qPCR were as follows: 37 °C for 15 min × 3 and 85 °C for 5 sec at 4°C. RNA was reverse transcribed into cDNA using SuperScript II Reverse Transcriptase (Thermo Fisher Scientific). RT-qPCR was performed on an AB 7300 Real-Time System (Applied Biosystems, Foster City, CA, USA) with TaqMan Universal PCR Master Mix and primer pairs specific for PSMA7 and β-actin. Gene expression was quantified using 2−ΔΔCt. The primers used were as follows: circ-FSCN1, (forward) 5′-CTTCTTCGAGTTCTGCGAC-3′ and (reverse) 5′-GTCCTGATTGGCAGACAGGTC-3′; FSCN1, (forward) 5′-CAGCCGAACAAAGGAGCAGG-3′ and (reverse) 5′-GGTCATGGTGGCAGTAGACG-3′; miR-506-3p, (forward) 5′-ACACTCATAAGGCACCCTTC-3′ and (reverse) 5′-TCTACTCAGAAGGGGAGTAC-3′; GAPDH, (forward) 5′-ATGTTGCAACCGGGAAGGAA-3′ and (reverse) 5′-AGGAAAAGCATCACCCGGAG-3′; U6, (forward) 5′-AGGGGCCGGACTCGTCATACT-3′ and (reverse) 5′-GGCGGCACCACCATGTACCCT-3′; SLC7A1, (forward) 5′-CACCAACTGGGACGACAT-3′ and (reverse) 5′-AGGCGTACAGGGATAGCA-3′. Cell migration assay Cell migration was analyzed using 24-well Transwell chambers (BD Biosciences, Franklin Lakes, NJ, USA). A549 and H1299 cells were plated into the upper chamber and 500 µL DMEM medium was added to the bottom chamber. Cells were cultured for 1 day, and cell counts were computed. Cell images were captured using a Zeiss Axio Observer D1 microscope (magnification, × 200). EdU analyses EdU assay kits (Thermo Fisher Scientific) were used for cell proliferation analyses. A549 and H1299 cells (1 × 105) were cultured in 6-well plates and then fixed with 4% formaldehyde. EdU-positive cells were detected using a Zeiss LSM 700 confocal microscope. Cell counting kit-8 (CCK8) assay A549 and H1299 cells were incubated in normal culture medium, and proliferation rates were detected post-transfection. Absorbance was captured using a microplate reader. RNA immunoprecipitation assay For the RNA immunoprecipitation (RIP) assay, a Magna RIP kit (Millipore, Billerica, MA, USA) was used. Cell lysates were generated using RIP buffer or NC IgG. The beads were cleaned, and the complexes were incubated to remove the proteins. Thereafter, we performed qRT-PCR assays. Dual-luciferase reporter assay Wild-type (Wt) or mutant (Mut) circ-FSCN1 or SLC7A1 3′-UTR sequences, including putative miR-506-3p binding sites, were cloned into the psi-CHECK vector (Promega, Madison, Wisconsin, USA). The clones were designated circ-FSCN1-Wt, SLC7A1-Wt, circ-FSCN1-Mut, and SLC7A1-Mut, respectively. A549 cells were transfected, and Renilla and firefly luciferase activities were captured post-transfection. Tumor xenograft models To make a subcutaneous NSCLC model, viable Wt or sh-circ-FSCN1 A549 cells (2 × 106) were injected into the right flank of the nude mice. Tumor sizes were monitored every 5 days for 30 days using a Vernier caliper. The tumor size was computed by 0.5 × length × width2. Relative Ki-67 expression was measured using immunohistochemical methods. For metastasis analysis, luc-A549 cells were stably transfected with NC. sh-circ-FSCN1 was suspended in sterile phosphate-buffered saline. After 4 weeks, lung metastasis was validated, and metastatic foci numbers in the lung tissues were counted. Statistical analysis Statistical analysis was performed utilizing GraphPad Prism (GraphPad, La Jolla, CA, USA). Data were analyzed using the Chi-square test, student′s t-test, and Pearson′s correlation test. Quantitative data are denoted by the mean ± SD. A p-value < 0.05 was regarded as statistically significant. Results hsa_circ_0004175 (circ-FSCN1) expression is increased in NSCLC tissues and cells Various investigations have validated the importance of circRNA function in regulating the tumor microenvironment [3,11]. In the current research, high-throughput sequencing (HTS) detection showed various circRNA expression profiles between cancer and adjacent tissues in NSCLC, including hsa_circ_0004175 (Fig. 1A). FISH showed that hsa_circ_0004175 was located in the cytoplasm. Data analysis found that the expression of hsa_circ_0004175 was elevated in tumor tissues compared to adjacent tissues in NSCLC (Fig. 1B). And hsa_circ_0004175 expression was consistent with the grade (Fig. 1C). The RT-qPCR results showed that hsa_circ_0004175 expression was increased in NSCLC cells, especially in H1299 and A549 cells compared to BEAS-2B cells (Fig. 1D). FISH showed that hsa_circ_0004175 was located in the cytoplasm, similar to 18s rRNA (Fig. 1E and 1F). RNase R digestion caused FSCN1 degradation at the mRNA level. However, hsa_circ_0004175 was not degraded by RNase R, suggesting that hsa_circ_0004175 is a circRNA (Fig. 1G and 1H). The present investigation revealed that hsa_circ_0004175 was generated by cyclizing exons from FSCN1, which was 2116 bp. The spliced mature circRNA was 548 bp (Fig. 1I), and hsa_circ_0004175 was circ-FSCN1. The expression of hsa_circ_0004175 (circ-FSCN1) increased in NSCLC tissues and cell lines. (A) High-throughput sequencing analysis identified a series of upregulated and downregulated miRNAs between normal and NSCLC tissues. (B–C) FISH detection shows the expression and subcellular localization of hsa_circ_0004175 in cancer and adjacent tissues. The data are expressed as the mean ± SD. ⁎⁎P < 0.01, ⁎⁎⁎P < 0.001. (D) RT-qPCR detection shows the expression of hsa_circ_0004175 in BEAS-2B, A549, H1299, H226, and MES-1 cells. The data are expressed as the mean ± SD. ⁎⁎P < 0.01, ⁎⁎⁎P < 0.001 vs. BEAS-2B. (E– F) FISH detection shows the expression and subcellular localization of hsa_circ_0004175 in NSCLC cells. (G–H) RT-qPCR detection shows the expression of hsa_circ_0004175 and FSCN1 in A549 and H1299 cells after treatment with RNase R. The data are expressed as the mean ± SD. ⁎⁎⁎P < 0.001. (I) Chromosomal location of hsa_circ_0004175. circ-FSCN1 downregulation inhibits migration and proliferation To determine whether circ-FSCN1 regulates NSCLC malignant progression, a circ-FSCN1 downregulation vector was made and transfected into H1299 and A549 cells. circ-FSCN1 downregulation inhibited the proliferative capability of H1299 and A549 cells (Fig. 2A and 2B). EdU detection showed that silencing circ-FSCN1 inhibited the proliferative capability of both A549 and H1299 cells (Fig. 2C and 2D). Transwell migration assays showed that silencing circ-FSCN1 inhibited the migration capability of both H1299 and A549 cells (Fig. 2E and 2F). In vivo tests confirmed that the downregulation of circ-FSCN1 inhibited the growth of A549 tumors in the subcutaneous tumor model in both tumor volume and weight (Fig. 2G–I). Immunohistochemical detection showed that circ-FSCN1 downregulation inhibited Ki-67 expression in tumor tissues (Fig. 2J and 2K), suggesting that circ-FSCN1 downregulation suppressed NSCLC cell proliferation and tumor growth. Imaging data after HE staining illustrated luc-A549 cell pulmonary metastasis, revealing that circ-FSCN1 silencing decreased pulmonary metastasis by lowering the metastatic foci count in the lung tissue (Fig. 2L–N). This data revealed that circ-FSCN1 downregulation inhibited NSCLC invasion. Downregulating circ-FSCN1 inhibited proliferation and migration both in vivo and in vitro. (A–B) CCK8 detection shows the proliferation of A549 and H1299 cells. The data are expressed as the mean ± SD. ⁎⁎⁎P < 0.001 vs. NC. (C–D) EdU detection shows the proliferation of A549 and H1299 cells. The data are expressed as the mean ± SD. ⁎⁎⁎P < 0.001 vs. NC. (E–F) Transwell detection shows the migration of A549 and H1299 cells. The data are expressed as the mean ± SD. ⁎⁎⁎P < 0.001 vs. NC. (G) Representative photographs of A549 tumor formation in xenografts of nude mice. (H) Summary of tumor volumes. The data are expressed as the mean ± SD. ⁎⁎⁎P < 0.001 vs. NC. (I) Summary of tumor weights in the mice. The data are expressed as the mean ± SD. ⁎⁎⁎P < 0.001 vs. NC. (J–K) Immunohistochemical detection shows the percentage of Ki-67-positive cells. The relative number of Ki-67-positive cells was calculated. The data are expressed as the mean ± SD. ⁎⁎⁎P < 0.001 vs. NC. (L) Live imaging detection shows pulmonary metastasis of luc-A549 cells. (M–N) The number of metastatic foci in lung tissue was calculated based on HE staining. The data are expressed as the mean ± SD. ⁎⁎⁎P < 0.001 vs. NC. miR-506-3p and SLC7A1 are downstream targets of circ-FSCN1 We performed AGO2 RIP to discover that endogenous circ-FSCN1 can be pulled down by anti-AGO2 antibody (Fig. 3A), which tells that circ-FSCN1 functions together with miRNA binding. Using a probe targeting the circ-FSCN1 junction site, we revealed that circ-FSCN1 and miR-506-3p were more abundant than NC (Fig. 3B). Both miR-506-3p and SLC7A1 are downstream targets of circ-FSCN1. (A) AGO2 RNA-binding protein immunoprecipitation. All data are shown as the mean ± SD. ***P < 0.001 vs. IgG. (B) circRNA pull-down assay. ***P < 0.001 compared to the negative control (NC) probe. (C) Prediction of miR-506-3p binding sites in circ-FSCN1. The mutant (Mut) version of circ-FSCN1 was constructed. (D) Relative luciferase activity was tested in A549 cells with circ-FSCN1-Wt or circ-FSCN1-Mut co-transfected with miR-506-3p mimics or NC mimics, ***P < 0.001. (E) Prediction of miR-506-3p binding sites within the 3′-UTR of SLC7A1. The Mut version of the 3′-UTR of SLC7A1 is shown. (F) Relative luciferase activity was tested in A549 cells with the 3′-UTR-Wt or 3′-UTR-Mut of SLC7A1 co-transfected with miR-506-3p mimics or NC mimics, ***P < 0.001. (G–L) RT-qPCR detection shows the expression of circ-FSCN1, miR-506-3p, and SLC7A1 in A549 and H1299 cells. The data are expressed as the mean ± SD. ⁎⁎⁎P < 0.001 vs. NC. #P < 0.05, ###P < 0.001 vs. sh-circ-FSCN1. To investigate the regulatory role of circ-FSCN1, bioinformatics analyses and luciferase reporter assays were conducted. Firstly, we employed circRNA-miRNA prediction databases to detect candidate miRNAs that might act with circ-FSCN1. Secondly, luciferase reporter results validated that miR-506-3p markedly reduced luciferase activity in Wt but not Mut cells (Fig. 3C–D), suggesting that miR-506-3p is a downstream target of circ-FSCN1. We further investigated candidate genes regulated by miR-506-3p. starBase, miRbase [12], miRDB, and TargetScan were employed to evaluate the potential genes. We analyzed genes by taking intersections and characterized SLC7A1 as a candidate target regulated by miR-506-3p. To verify the interactive correlations between miR-506-3p and SLC7A1, Mut/Wt SLC7A1 3′-UTR sequences—including miR-506-3p binding sites—were built into luciferase reporter vectors and transfected into A549 cells with or without miR-506-3p mimics. The results showed that miR-506-3p suppressed luciferase activity in Wt rather than Mut cells (Fig. 3E and 3F), informing that SLC7A1 was a target of miR-506-3p. RT-qPCR showed that circ-FSCN1 expression was reduced after transfection with the circ-FSCN1 silencing vector. However, suppressing miR-506-3p or overexpressing SLC7A1 did not influence circ-FSCN1 expression in H1299 and A549 cells (Fig. 3G and 3H). This result indicated that miR-506-3p and SLC7A1 are downstream molecules of circ-FSCN1. Moreover, silencing circ-FSCN1 increased miR-506-3p expression, yet SLC7A1 overexpression did not influence sh-circ-FSCN1-induced miR-506-3p expression (Fig. 3I and 3J). This indicated that miR-506-3p is regulated by circ-FSCN1. Additionally, circ-FSCN1 silencing reduced SLC7A1 expression, though suppressing miR-506-3p reversed the inhibitory effects of sh-circ-FSCN1 on SLC7A1 expression. After transfections with SLC7A1 overexpression vectors, SLC7A1 expression increased (Fig. 3K and 3L), suggesting that circ-FSCN1 promotes SLC7A1 expression through miR-506-3p. miR-506-3p downregulation or SLC7A1 overexpression reverses the inhibitory effect of sh-circ-FSCN1 on proliferation and migration EdU assays showed that miR-506-3p suppression or SLC7A1 overexpression restored proliferation in H1299 and A549 cells post-circ-FSCN1 silencing (Fig. 4A–D). Transwell migration assays also showed that suppressing miR-506-3p or overexpressing SLC7A1 rescued NSCLC cell migration following sh-circ-FSCN1 (Fig. 4E–H). Immunofluorescence detection showed that silencing circ-FSCN1 increased ROS accumulation. However, inhibiting miR-506-3p or overexpressing SLC7A1 reversed the enhancing effects of sh-circ-FSCN1 on ROS accumulation in H1299 and A549 cells (Fig. 4I–L). Downregulation of miR-506-3p or overexpression of SLC7A1 reversed the inhibitory effect of sh-circ-FSCN1 on the proliferation and migration of A549 and H1299 cells. (A–D) EdU detection shows the proliferation ability in both A549 and H1299 cells. The data are expressed as the mean ± SD. ⁎⁎⁎P < 0.001 vs. NC. ###P < 0.001 vs. sh-circ-FSCN1. (E–H) Transwell assay for detecting the migration ability. The data are expressed as the mean ± SD. ⁎⁎⁎P < 0.001 vs. NC. ###P < 0.001 vs. sh-circ-FSCN1. (I–L) Immunofluorescence detection shows the level of ROS in A549 and H1299 cells. The data are expressed as the mean ± SD. ⁎⁎⁎P < 0.001 vs. NC. ###P < 0.001 vs. sh-circ-FSCN1. SLC7A1 overexpression reverses the inhibitory effects of miR-506-3p on proliferation and migration RT-qPCR results showed that the overexpression of miR-506-3p enhanced its expression levels in A549 and H1299 cells, while the upregulation of SLC7A1 did not revert the expression of miR-506-3p (Fig. 5A and 5B). In addition, miR-506-3p overexpression suppressed SLC7A1 expression. Nevertheless, after transfection with a heterologous SLC7A1 overexpression vector, SLC7A1 expression significantly improved in H1299 and A549 cells (Fig. 5C and 5D). Overexpression of SLC7A1 reversed the inhibitory effect of miR-506-3p on the proliferation and migration of A549 and H1299 cells. (A–D) RT-qPCR detection shows the expression of circ-FSCN1, miR-506-3p, and SLC7A1 in A549 and H1299 cells. The data are expressed as the mean ± SD. ⁎⁎⁎P < 0.001 vs. NC. ###P < 0.001 vs. mimic. (E–H) EdU detection shows the proliferation ability of A549 and H1299 cells. The data are expressed as the mean ± SD. ⁎⁎⁎P < 0.001 vs. NC. ###P < 0.001 vs. mimic. (I–L) Transwell assay for detecting migration ability. The data are expressed as the mean ± SD. ⁎⁎⁎P < 0.001 vs. NC. ###P < 0.001 vs. mimic. (M–P) Immunofluorescence detection shows the level of ROS in both A549 and H1299 cells. The data are expressed as the mean ± SD. ⁎⁎⁎P < 0.001 vs. NC. ###P < 0.001 vs. mimic. EdU data showed that SLC7A1 overexpression restored the proliferative capacity of H1299 and A549 cells after miR-506-3p overexpression (Fig. 5E–H). The Transwell migration assay confirmed that SLC7A1 overexpression reinstated the migration of NSCLC cells following the overexpression of miR-506-3p (Fig. 5I–L). Immunofluorescence detection showed that miR-506-3p overexpression increased ROS accumulation. However, SLC7A1 overexpression reversed the promoting effects of miR-506-3p on ROS accumulation in both H1299 and A549 cell lines (Fig. 5M–P). Discussion Numerous studies have confirmed that circRNA plays an important role in regulating the malignant progression of various cancers, such as breast cancer [[13], [14], [15], [16]]. Studies have also found that circRNAs regulate the malignant progression of NSCLC, specifically highlighting circ-HERC1, circ-PPAPDC1A, circ-103809, and circ-SATB2 [10,[17], [18], [19]]. The current investigation indicated that the expression of circ-FSCN1 was elevated in NSCLC cancer tissues compared to para-carcinoma tissue. circ-FSCN1 has been located mainly in the cytoplasm [[20], [21], [22]], and it is generated by cyclizing exons from FSCN1. The data have illustrated elevated circ-FSCN1 expression in the NSCLC cell lines. Various studies have confirmed that FSCN1 is associated with immune infiltrations and inflammatory factors in LC [23]. Silencing FSCN1 in A549 cells influences malignant phenotypes, suppressing proliferation and migration and promoting apoptosis [24]. However, whether circ-FSCN1 regulates NSCLC malignant progression is largely unknown. The present study indicated that the downregulation of circ-FSCN1 inhibited the proliferation and migration of H1299 and A549 cells. The in vivo results confirmed that silencing circ-FSCN1 inhibited the growth and invasion of A549 tumors, suggesting that circ-FSCN1 plays an important function in NSCLC progression. circRNA might regulate gene expression via miRNA sponging [25,26]. The current investigation applied bioinformatics analysis and found that circ-FSCN1 could interact with miR-506-3p. This was verified with luciferase reporter data. Previous research showed that high miR-506-3p expression reduced the migration and proliferation of various cancers, including LC [[27], [28], [29], [30], [31]]. The present study revealed that silencing circ-FSCN1 enhanced miR-506-3p expression while suppressing miR-506-3p restored cell proliferation and migration after circ-FSCN1 silencing. Additional studies have discovered that circ-FSCN1 might interact with the 3′-UTR of SLC7A1. High SLC7A1 expression in high-grade serous ovarian cancer promotes tumor progression [32]. SLC7A1 expression in NSCLC tumor tissues surpasses that in normal tissues. SLC7A1 depletion in patient-derived organoid and xenograft models suppresses KRAS-driven NSCLC growth [33]. The current research discovered that circ-FSCN1 silencing downregulated SLC7A1 expression. Notably, high SLC7A1 expression promotes tumor energy metabolism reprogramming to induce tumor epithelial-mesenchymal transition (EMT) [34]. The present investigation revealed that SLC7A1 overexpression reinstated cell migration and proliferation after circ-FSCN1 silencing. Further studies detected that miR-506-3p overexpression inhibited SLC7A1 expression. This work showed that SLC7A1 overexpression or miR-506-3p suppression reversed cell proliferation and migration after circ-FSCN1 silencing. Various studies have confirmed that glutamate is the classical ferroptosis inducer. The SLC7A1/GPX-4 pathway is a typical defense mechanism against ferroptosis, playing a crucial role in regulating intracellular ROS [35,36]. The current investigations revealed that the suppression of miR-506-3p or the overexpression of SLC7A1 counteracted the promoting effects of sh-circ-FSCN1 on ROS accumulation in both H1299 and A549 cells. SLC7A1 overexpression reversed the promoting effects of miR-506-3p on ROS accumulation in H1299 and A549 cells, suggesting that circ-FSCN1 influences ferroptosis and cell viability via the miR-506-3p/SLC7A1 pathway in NSCLC. Conclusion The present study indicated that circ-FSCN1 improved SLC7A1 expression by sequestering miR-506-3p. Therefore, our team identified the circ-FSCN1/miR-506-3p/SLC7A1 loop and its biological effects in the context of malignant NSCLC, suggesting its potential as a candidate therapeutic marker for NSCLC. Circ-FSCN1/miR-506-3p/SLC7A1 axis contributes to ferroptosis regulation, this study uncovered novel mechanistic insights into NSCLC progression. Ethics approval and consent to participate This study was approved by the Medical Ethics Committee of Shanghai University of Medicine and Health Sciences and were conducted in strict accordance with relevant laboratory animal regulations. The study was carried out in compliance with the ARRIVE guidelines (https://arriveguidelines.org). Consent for publication Not applicable. Availability of data and material The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. Disclosure of conflict of interest The authors declared that there was no conflict of interest associated with the manuscript. Funding This work was funded by the National Natural Science Foundation of China (No. 52103171, 82127807), Shanghai "Science and Technology Innovation Action Plan" Natural Science Project (24ZR1429400), Shanghai Municipal Health Commission Medical New Technology Research and Transformation Seed Program Project Plan Assignment (2024ZZ2056), Shanghai Science and Technology Program (23010502600), the National Key Research and Development Program of China (2020YFA0909000), and Shanghai Key Laboratory of Molecular Imaging (18DZ2260400). CRediT authorship contribution statement Wenxi Yu: Writing – original draft, Visualization, Validation, Software, Resources, Methodology, Investigation, Formal analysis, Data curation. Jiao Liu: Writing – original draft, Visualization, Validation, Software, Resources, Methodology, Investigation, Formal analysis, Data curation. Mingming Jin: Writing – review & editing, Supervision, Project administration, Funding acquisition, Conceptualization. Gang Huang: Writing – review & editing, Supervision, Project administration, Funding acquisition, Conceptualization. Qingqing Huang: Writing – review & editing, Supervision, Project administration, Funding acquisition, Conceptualization. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Acknowledgments Not applicable. Contributor Information Wenxi Yu, Email: denice8023@163.com. Jiao Liu, Email: 12023250@shutcm.edu.cn. Mingming Jin, Email: asdjinmingming@126.com. Gang Huang, Email: huanggang502@sumhs.edu.cn. Qingqing Huang, Email: qingqinghuang80@163.com. References Associated Data Data Availability Statement The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.